- Home
- MTVA vs HTCR Comparison
MTVA vs HTCR Comparison
Compare MTVA & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- HTCR
- Stock Information
- Founded
- MTVA 2014
- HTCR 2009
- Country
- MTVA United States
- HTCR Japan
- Employees
- MTVA N/A
- HTCR N/A
- Industry
- MTVA
- HTCR EDP Services
- Sector
- MTVA
- HTCR Technology
- Exchange
- MTVA NYSE
- HTCR Nasdaq
- Market Cap
- MTVA 15.1M
- HTCR 12.8M
- IPO Year
- MTVA N/A
- HTCR 2022
- Fundamental
- Price
- MTVA $0.69
- HTCR $0.58
- Analyst Decision
- MTVA Strong Buy
- HTCR
- Analyst Count
- MTVA 2
- HTCR 0
- Target Price
- MTVA $7.50
- HTCR N/A
- AVG Volume (30 Days)
- MTVA 599.8K
- HTCR 2.5M
- Earning Date
- MTVA 05-14-2025
- HTCR 05-15-2025
- Dividend Yield
- MTVA N/A
- HTCR 3.56%
- EPS Growth
- MTVA N/A
- HTCR N/A
- EPS
- MTVA N/A
- HTCR N/A
- Revenue
- MTVA N/A
- HTCR $28,947,523.00
- Revenue This Year
- MTVA N/A
- HTCR N/A
- Revenue Next Year
- MTVA N/A
- HTCR $8.59
- P/E Ratio
- MTVA N/A
- HTCR N/A
- Revenue Growth
- MTVA N/A
- HTCR 59.42
- 52 Week Low
- MTVA $0.63
- HTCR $0.51
- 52 Week High
- MTVA $5.30
- HTCR $3.38
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- HTCR 47.24
- Support Level
- MTVA N/A
- HTCR $0.53
- Resistance Level
- MTVA N/A
- HTCR $0.65
- Average True Range (ATR)
- MTVA 0.00
- HTCR 0.06
- MACD
- MTVA 0.00
- HTCR 0.00
- Stochastic Oscillator
- MTVA 0.00
- HTCR 25.15
About MTVA METAVIA INC
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
About HTCR Heartcore Enterprises Inc.
HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.